HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.

Abstract
The effects of melanotropin release-inhibiting factor, a tripeptide (Pro-Leu-Gly-NH2) derived from the hypothalamus, and its enzymatically stable analog, cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to male Sprague-Dawley rats was determined. Oral administration of haloperidol (1.5 mg/kg per day) for 21 days induced supersensitivity of dopamine receptors as shown by enhanced locomotor activity in response to apomorphine, and an increase in the number of binding sites for [3H]spiroperidol in the striatum. Subcutaneous administration of Pro-Leu-Gly-NH2 or cyclo(Leu-Gly) in doses of 2 mg/kg per day, given prior to the injection of haloperidol, inhibited both the enhanced response to apomorphine as well as the increase in the number of binding sites for [3H]spiroperidol in the striatum. Chronic administration of either of the peptides alone did not modify either the apomorphine-induced response or the binding of [3H]spiroperidol in the striatum. These studies suggest that the hypothalamic peptide, Pro-Leu-Gly-NH2 and its long-acting analog, cyclo (Leu-Gly) can prevent the development of both behavioral and biochemical supersensitivity of dopamine receptors in brain induced by neuroleptic drugs and that these peptides may be useful in preventing the development of neuroleptic-induced tardive dyskinesia.
AuthorsH N Bhargava
JournalNeuropharmacology (Neuropharmacology) Vol. 23 Issue 4 Pg. 439-44 (Apr 1984) ISSN: 0028-3908 [Print] England
PMID6145116 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Dipeptides
  • Neuropeptides
  • Peptides, Cyclic
  • Receptors, Dopamine
  • Spiperone
  • cyclo(leucylglycine)
  • MSH Release-Inhibiting Hormone
  • Haloperidol
  • Apomorphine
Topics
  • Animals
  • Apomorphine (pharmacology)
  • Body Weight (drug effects)
  • Cell Membrane (metabolism)
  • Corpus Striatum (metabolism, ultrastructure)
  • Dipeptides (pharmacology)
  • Haloperidol (pharmacology)
  • In Vitro Techniques
  • MSH Release-Inhibiting Hormone (pharmacology)
  • Male
  • Motor Activity (drug effects)
  • Neuropeptides
  • Peptides, Cyclic
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine (physiology)
  • Spiperone (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: